Literature DB >> 28286433

Hepatic Overlap Syndrome Improved With Infliximab.

Nir Hilzenrat1, Esther Lamoureux1, Albert Cohen1, Murray Baron1.   

Abstract

Entities:  

Year:  2006        PMID： 28286433      PMCID： PMC5335630     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  12 in total

1.  Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha.

Authors:  Ewan H Forrest; K A Oien; S Dickson; D Galloway; P R Mills
Journal:  Liver       Date:  2002-08

Review 2.  Cytokines and liver diseases.

Authors:  H Tilg
Journal:  Can J Gastroenterol       Date:  2001-10       Impact factor: 3.522

3.  Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

Authors:  Herbert Tilg; Rajiv Jalan; Arthur Kaser; Nathan A Davies; Felix A Offner; Stephen J Hodges; Othmar Ludwiczek; Deborah Shawcross; Heinz Zoller; Akeel Alisa; Rajeshwar P Mookerjee; Ivo Graziadei; Christian Datz; Michael Trauner; Detlef Schuppan; Peter Obrist; Wolfgang Vogel; Roger Williams
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

Review 4.  Tumor necrosis factor alpha and toxicology.

Authors:  M I Luster; P P Simeonova; R Gallucci; J Matheson
Journal:  Crit Rev Toxicol       Date:  1999-09       Impact factor: 5.635

5.  Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.

Authors:  Manuela Neuman; Paul Angulo; Izabella Malkiewicz; Roberta Jorgensen; Neil Shear; E Rolland Dickson; Julia Haber; Gady Katz; Keith Lindor
Journal:  J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 4.029

6.  Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients.

Authors:  Aldona Kasprzak; Maciej Zabel; Wiesława Biczysko; Jacek Wysocki; Agnieszka Adamek; Rafał Spachacz; Joanna Surdyk-Zasada
Journal:  J Histochem Cytochem       Date:  2004-01       Impact factor: 2.479

7.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.

Authors:  S L Taylor; P J Dean; C A Riely
Journal:  Am J Surg Pathol       Date:  1994-01       Impact factor: 6.394

9.  Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis.

Authors:  Andreas Geier; Christoph G Dietrich; Sebastian Voigt; Suk-Kyum Kim; Thomas Gerloff; Gerd A Kullak-Ublick; Johann Lorenzen; Siegfried Matern; Carsten Gartung
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

10.  Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.

Authors:  J R Peterson; F C Hsu; P A Simkin; M H Wener
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.